A rating of 54 puts Constellation Pharmaceuticals Inc (CNST) near the middle of the Biotechnology industry according to InvestorsObserver. Constellation Pharmaceuticals Inc's score of 54 means it scores higher than 54% of stocks in the industry. Constellation Pharmaceuticals Inc also received an overall rating of 39, putting it above 39% of all stocks. Biotechnology is ranked 99 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Constellation Pharmaceuticals Inc Stock Today?
Constellation Pharmaceuticals Inc (CNST) stock is trading at $21.97 as of 10:54 AM on Wednesday, Apr 21, a rise of $0.37, or 1.71% from the previous closing price of $21.60. The stock has traded between $21.10 and $22.27 so far today. Volume today is low. So far 122,428 shares have traded compared to average volume of 427,726 shares.
Click Here to get the full Stock Score Report on Constellation Pharmaceuticals Inc (CNST) Stock.
